Health Sciences Acquisitions Corporation 2
HSAQ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $42 | $19 | $18 | $22 |
| Short-Term Investments | $54 | $15 | $32 | $45 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $2 | $2 | $2 |
| Total Curr. Assets | $98 | $36 | $52 | $69 |
| Property Plant & Equip (Net) | $3 | $3 | $3 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $2 | $2 | $2 | $2 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $1 |
| Total NC Assets | $7 | $7 | $7 | $7 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $105 | $43 | $59 | $76 |
| Liabilities | – | – | – | – |
| Payables | $8 | $5 | $6 | $5 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $5 | $4 | $4 | $4 |
| Other Curr. Liab. | $7 | $7 | $5 | $6 |
| Total Curr. Liab. | $21 | $17 | $15 | $16 |
| LT Debt | $1 | $1 | $2 | $2 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $39 | $24 | $25 | $25 |
| Total NC Liab. | $40 | $25 | $27 | $27 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $61 | $43 | $42 | $43 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$369 | -$348 | -$329 | -$310 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $413 | $348 | $345 | $343 |
| Total Equity | $44 | $0 | $17 | $33 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $105 | $43 | $59 | $76 |
| Net Debt | -$40 | -$17 | -$16 | -$20 |